T3/rT3-ratio is associated with insulin resistance independent of TSH

Hormone and Metabolic Research

Volumn 43, Issue 2, 2011, Pages 130-134

  Ruhla, S ^a,b   Arafat, A M ^a,b   Weickert, M O ^b,c   Osterhoff, M ^a,b   Isken, F ^a,b,d   Spranger, J ^a,b   Schofl C ^a,d   Pfeiffer, A F H ^a,b   Mohlig M ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

diabetes mellitus type 2; insulin resistance; thyroid function

Indexed keywords

3,3',5' TRIIODOTHYRONINE; LIOTHYRONINE; THYROTROPIN;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; SEX; THYROID FUNCTION; THYROID HORMONE METABOLISM;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; THYROTROPIN; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 79551597045     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1267997     Document Type: Article

References (42)

1. Ronnemaa T, Laakso M, Pyorala K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991 11 80-90
2. Skarfors ET, Selinus KI, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 1991 303 755-760
3. Zimmet P, Dowse G, Bennett P. Hyperinsulinaemia is a predictor of non-insulin-dependent diabetes mellitus. Diabetes Metab 1991 17 101-108
4. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003 88 2527-2533
5. Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990 39 897-901
6. Simon D, Charles MA, Nahoul K, Orssaud G, Kremski J, Hully V, Joubert E, Papoz L, Eschwege E. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab 1997 82 682-685
7. Ohguni S, Notsu K, Kato Y. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med 1995 34 339-341
8. Cavallo-Perin P, Bruno A, Boine L, Cassader M, Lenti G, Pagano G. Insulin resistance in Graves' disease: a quantitative in-vivo evaluation. Eur J Clin Invest 1988 18 607-613
9. Dimitriadis G, Baker B, Marsh H, Mandarino L, Rizza R, Bergman R, Haymond M, Gerich J. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985 248 E593-E601
10. Tene C, Zarate A, Basurto L, Islas S, Revilla C, Ochoa R, Galvan R, Santos P. Correction of insulin resistance in methimazole-treated patients with Graves disease. Rev Invest Clin 2001 53 531-535
11. Yavuz DG, Yuksel M, Deyneli O, Ozen Y, Aydin H, Akalin S. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clin Endocrinol (Oxf) 2004 61 515-521
12. Heemstra KA, Smit JW, Eustatia-Rutten CF, Heijboer AC, Frolich M, Romijn JA, Corssmit EP. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial. Clin Endocrinol (Oxf) 2006 65 737-744
13. Rochon C, Tauveron I, Dejax C, Benoit P, Capitan P, Fabricio A, Berry C, Champredon C, Thieblot P, Grizard J. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Lond) 2003 104 7-15
14. Stanicka S, Vondra K, Pelikanova T, Vlcek P, Hill M, Zamrazil V. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 2005 43 715-720
15. Owecki M, Nikisch E, Sowinski J. Hypothyroidism has no impact on insulin sensitivity assessed with HOMA-IR in totally thyroidectomized patients. Acta Clin Belg 2006 61 69-73
16. Harris PE, Walker M, Clark F, Home PD, Alberti KG. Forearm muscle metabolism in primary hypothyroidism. Eur J Clin Invest 1993 23 585-588
17. Jackson IM, Prentice CR, McKiddie MT. The effect of hypothyroidism on glucose tolerance and insulin metabolism. J Endocrinol 1970 47 257-258
18. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007 92 491-496
19. Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 2006 91 3337-3343
20. Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, Hur JY, Kim YT, Lee KW, Kim SH. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 2009 62 301-305
21. Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Schufl C, Pfeiffer AF, Muhlig M. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 2010 72 696-701
22. Mueller A, Schufl C, Dittrich R, Cupisti S, Oppelt PG, Schild RL, Beckmann MW, Haberle L. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome. Hum Reprod 2009 24 2924-2930
23. Bakker SJ, ter Maaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001 86 1206-1211
24. Ortega E, Koska J, Pannacciulli N, Bunt JC, Krakoff J. Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. Eur J Endocrinol 2008 158 217-221
25. Kuhrle J. Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination. Best Pract Res Clin Endocrinol Metab 2007 21 173-191
26. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008 29 898-938
27. Peeters RP, van der Deure WM, Visser TJ. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur J Endocrinol 2006 155 655-662
28. Matthaei S, Stumvoll M, Kellerer M, Huring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2000 21 585-618
29. Fischer A, Fisher E, Muhlig M, Schulze M, Hoffmann K, Weickert MO, Schueler R, Osterhoff M, Pfeiffer AF, Boeing H, Spranger J. KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts. Diabetes Care 2008 31 87-89
30. Marassi MP, Fortunato RS, da Silva AC, Pereira VS, Carvalho DP, Rosenthal D, da Costa VM. Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-pubertal and adult rats. J Endocrinol 2007 192 121-130
31. Lisboa PC, Cabanelas AP, Curty FH, Oliveira KJ, Ortiga-Carvalho TM, Moura EG, Nascimento-Saba CC, Rosenthal D, Pazos-Moura CC. Modulation of type 2 iodothyronine deiodinase activity in rat thyroid gland. Horm Metab Res 2007 39 538-541
32. Fisher DA. Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clinical Chemistry 1996 42 135-139
33. Kuhrle J. Thyroid hormone metabolism and action. Z Arztl Fortbild Qualitatssich 2004 98 17-24
34. Chidakel A, Mentuccia D, Celi FS. Peripheral metabolism of thyroid hormone and glucose homeostasis. Thyroid 2005 15 899-903
35. Shimizu Y, Shimazu T. Thyroid hormone augments GLUT4 expression and insulin-sensitive glucose transport system in differentiating rat brown adipocytes in culture. J Vet Med Sci 2002 64 677-681
36. Torrance CJ, Devente JE, Jones JP, Dohm GL. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats. Endocrinology 1997 138 1204-1214
37. Silva JE, Larsen PR. Hormonal regulation of iodothyronine 5-deiodinase in rat brown adipose tissue. American Journal of Physiology 1986 251 E639-E643
38. Mills I, Barge RM, Silva JE, Larsen PR. Insulin stimulation of iodothyronine 5-deiodinase in rat brown adipocytes. Biochem Biophys Res Commun 1987 143 81-86
39. Heemstra KA, Soeters MR, Fliers E, Serlie MJ, Burggraaf J, van Doorn MB, van der Klaauw AA, Romijn JA, Smit JW, Corssmit EP, Visser TJ. Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting. J Clin Endocrinol Metab 2009 94 2144-2150
40. Sato K, Robbins J. Thyroid hormone metabolism in primary cultured rat hepatocytes. Effects of glucose, glucagon, and insulin. J Clin Invest 1981 68 475-483
41. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992 135 1042-1050
42. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004 27 1487-1495